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Juvenile myoclonic epilepsyExecutive dysfunction is reported in juvenile myoclonic epilepsy (JME). However, batteries employed in
previous studies included no more than three tests of executive function. In this study, we aimed to assess
executive and attentional functions in JME using a comprehensive battery of eight tests (encompassing ﬁf-
teen subtests). We also evaluated neuropsychological proﬁles using a clinical criterion of severity and corre-
lated these ﬁndings with epilepsy clinical variables and the presence of psychiatric disorders. We
prospectively evaluated 42 patients with JME and a matched control group with Digit Span tests (forward
and backward), Stroop Color-Word Test, Trail Making Test, Wisconsin Card-Sorting Test, Matching Familiar
Figures Test and Word Fluency Test. We estimated IQ with the Matrix Reasoning and Vocabulary subtests
of the Wechsler Abbreviated Intelligence Scale. The patients with JME showed speciﬁc deﬁcits in working
memory, inhibitory control, concept formation, goal maintenance, mental ﬂexibility, and verbal ﬂuency.
We observed attentional deﬁcits in processes such as alertness and attention span and those requiring
sustained and divided attention. We found that 83.33% of the patients had moderate or severe executive dys-
function. In addition, attentional and executive impairment was correlated with higher frequency of seizures
and the presence of psychiatric disorders. Furthermore, executive dysfunction correlated with a longer dura-
tion of epilepsy. Our ﬁndings indicate the need for comprehensive neuropsychological batteries in patients
with JME, in order to provide a more extensive evaluation of attentional and executive functions and to
show that some relevant deﬁcits have been overlooked.
© 2012 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
According to the International League Against Epilepsy [1], juve-
nile myoclonic epilepsy (JME) is an idiopathic form of generalized
epilepsy. The long-held belief that idiopathic epilepsies do not present
with cognitive deﬁcits has been contradicted by evidence that patients
with JME have speciﬁc cognitive dysfunctions, mainly in functions re-
lated to the frontal lobes [2–9].
Using a working memory paradigm, Swartz et al. [10] showed that
patients with JME had impairments very similar to those found in
patients with frontal lobe epilepsy (FLE). Devinsky et al. [11] studied
cognitive frontal lobe function in 16 patients with JME and 15 pa-
tients with FLE. The authors observed a signiﬁcant difference between
the two groups in terms of their performance on tests requiring
psychomotor speed, planning, verbal ﬂuency, abstract reasoning, and
concept formation; the patients with JME performing more poorly.pos, 785, 05403-903 São Paulo,
e).
evier OA license.Sonmez et al. [12] and Pascalicchio et al. [13] reported similar results,
suggesting that there is speciﬁc impairment of executive function
processes in JME. In addition, Piazzini et al. [14] investigated frontal
cognitive dysfunction in patients with JME, comparing them with
patients with FLE, patients with temporal lobe epilepsy (TLE), and
control subjects. Those authors found that patients with JME had
cognitive impairment, as evidenced by their performance on the
Word Fluency Test and Wisconsin Card-Sorting Test (WCST), which
was similar to that of the patients with FLE.
To date, all of the evidence of executive dysfunction in patients
with JME has been based on the results of studies using test batteries
that included no more than three tests. However, executive and
attentional functions encompass various functions associated with
frontal lobe functioning, such as mental ﬂuency, mental ﬂexibility,
working memory, planning, concept formation, inhibitory control,
and the attentional processes themselves. Therefore, executive and
attentional functions cannot be adequately measured with a limited
battery of tests. When interpreting the ﬁndings of frontal lobe dys-
function in patients with JME, one must bear in mind the importance
of all aspects of executive and attentional functions, the evaluation
of which requires the use of a more extensive neuropsychological
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dysfunction in patients with JME using a comprehensive battery
of eight tests (encompassing ﬁfteen subtests) evaluating attention
span, working memory, sustained and divided attention, mental
ﬂuency and ﬂexibility, concept formation, maintenance of goals,
inhibitory control and verbal ﬂuency. In addition, we attempted to
identify neuropsychological proﬁles using a clinical criterion of
severity and correlate these ﬁndings with epilepsy clinical variables
and the presence of psychiatric disorders. To our knowledge, it is
the ﬁrst study of its kind.
2. Methods
2.1. Study population
2.1.1. Patients
We prospectively evaluated 42 consecutive adolescent and adult
patients with an unequivocal diagnosis of JME, according to the In-
ternational League Against Epilepsy [1] proposal for syndrome clas-
siﬁcation, followed in the Ambulatory Clinic of Epilepsy in the
Hospital das Clinicas of the University of São Paulo, Brazil, from
2007 to 2009.
Twenty patients (47.6%) were male with mean age of 26.57 (SD:
8.38; ranging from 16 to 48 years), 10.10 (SD: 1.83) years of education
and estimated IQ of 91.5 (SD: 9.94).
2.1.2. Controls
A control group of 42 healthy volunteers was matched to the
patients as to gender (p=0.827), age (p=0.959), years of education
(p=0.653) and socioeconomic status. The controls were evaluated
by a psychiatrist and a neurologists to rule out psychiatric and neuro-
logical disorders.
The exclusion criteria for patients and controls included the
following: at least 16 years of age, an estimated IQ below 80, clinical
signs of drug intoxication or any other condition leading to cognitive
impairment, diagnosis of a psychiatric disorder, alcohol or drug abuse,
and any brain-related surgical intervention.
2.2. Measures
2.2.1. Neuropsychological evaluation
Patients with JME and control subjects were evaluated with a
comprehensive battery of neuropsychological tests, all of which
were administered, in a standard sequence, by a trained neuropsy-
chologist. All patients should have had at least 48 h of seizure-free
status before neuropsychological evaluation.
Our battery of neuropsychological tests comprised tests evaluating
executive and attentional functions in their broadest aspects. The tests
were selected from among those included in collections of neuropsy-
chological tests [15,16], from studies of generalized epilepsies and
JME [17] and from studies correlating neuropsychological test results
with frontal lobe functions [18].
The following tests were used for the measurement of executive
and attentional functions:
• the Digit Span Forward and Digit Span Backward tests [19] which
evaluate attention span, working memory, and mental control with
auditory–verbal stimuli;
• the Stroop Color-Word Test [20] which evaluates the ability to inhibit
responses to visual–verbal stimuli;
• the Trail Making Test [16] which evaluates self-monitoring, visuospa-
tial orientation for simple and alternating sequences, sustained atten-
tion, and divided attention;
• the WCST [21] which evaluates concept building, mental ﬂexibility,
and goal maintenance;• the Matching Familiar Figures Test [22] which evaluates the ability to
inhibit responses to visual stimuli; and
• the Word Fluency Test [16] which evaluates verbal ﬂuency.
The IQ of each subject was estimated with the Matrix Reasoning
and Vocabulary subtests of the Wechsler Abbreviated Intelligence
Scale [19]. All participating patients gave their written informed con-
sent to participate in this study, which was approved by the Research
Ethics Committee of the Hospital das Clínicas.
2.2.2. Clinical criteria of severity
We established clinical criteria for the evaluation of the degree of
executive dysfunction in patients with JME which were based on the
model used by Rzezak et al. [23]. Accordingly, patients whose gross
score on a given test was at least one standard deviation below the
mean result for at least two paradigms of the same test in control
subjects were categorized as having executive dysfunction in relation
to the function(s) evaluated by that test. Executive dysfunction was
classiﬁed as mild if identiﬁed in the results of two tests, moderate if
identiﬁed in those of three or four tests, and severe if identiﬁed in
those of ﬁve or more tests.
2.2.3. Clinical variables
For the patients with JME, we evaluated the age of onset, duration of
epilepsy, frequency of myoclonic seizures, frequency of generalized
tonic-clonic (GTC) seizures, frequency of absence seizures, VPA doses
and family history of epilepsy. Interictal and ictal eletroencephalographic
ﬁndings were also evaluated.
We also assessed family history of psychiatric disorders and per-
sonal history of psychiatric disorders. The patients were interviewed
and followed by a clinical psychiatrist and diagnosed according to
the criteria of DSM-IV.
2.3. Statistical analysis
The descriptive statistics included means and standard deviations
calculated for each variable. Demographic variables (sex, age, and
level of education) were compared using the chi-square test in
order to verify that the two groups were matched. The differences
between the two groups in terms of the estimated IQ were analyzed
using independent t-tests for continuous variables. We compared
performance on the neuropsychological tests using analysis of
covariance in which the estimated IQ was the covariate. The level of
signiﬁcance was set at p≤0.05.
The correlation between the clinical variables and the scores of pa-
tients with JME on the Beck Depression Inventory, State-Trait Anxiety
Inventory, and neuropsychological tests was compared using Pearson's
and Spearman's correlation coefﬁcients. The level of signiﬁcancewas set
at p≤0.05. For the statistical analysis, we used the Statistical Package
for the Social Sciences, version 11.0.
3. Results
3.1. Neuropsychological ﬁndings
Therewas a signiﬁcant difference between the two groups in terms
of the estimated IQ (p=0.042). Therefore, as previously mentioned,
we used analysis of covariance with the estimated IQ as a covariate.
As can be seen in Table 1, the patients with JME performed more
poorly than did the control subjects on the following: Digit Span For-
ward (p=0.001); Digit Span Backward (p=0.001); time to comple-
tion of Stroop Color-Word Test 1 (p=0.001), Stroop Color-Word Test
2 (p=0.001), and Stroop Color-Word Test 3 (p=0.001); number of
errors on Stroop Color-Word Test 3 (p=0.030); time to completion
on the Trail Making Test, part A (p=0.001) and part B (p=0.001);
number of errors on the Trail Making Test, part B (p=0.006);
Table 1
Analysis of covariance, with estimated IQ as the covariate, comparing patients with
juvenile myoclonic epilepsy and control subjects on neuropsychological tests.
Test JME
(n=42)
Controls
(n=42)
p
(ANCOVA)
DSF 5.09±1.73 7.02±1.90 0.001
DSB 3.61±1.56 5.35±1.84 0.001
SCWT-1 time 21.78±5.71 14.21±2.78 0.001
SCWT-1 errors 0.03±0.15 0.02±0.11 0.993
SCWT-2 time 26.61±8.0 17.68±4.22 0.001
SCWT-2 errors 0.16±0.0 0.43±0.00 0.030
SCWT-3 time 36.73±10.72 23.80±5.71 0.001
SCWT-3 errors 1.90±0.23 1.87±0.57 0.001
TMT-A time 39.59±10.96 29.21±9.75 0.001
TMT-A errors 0.09±0.29 0.04±0.21 0.541
TMT-B time 73.71±27.32 57.76±24.75 0.006
TMT-B errors 0.80±1.04 0.14±0.41 0.001
WFT(letter F) 9.19±2.22 13.97±3.97 0.001
WFT(letter A) 8.52±2.22 12.35±3.53 0.001
WFT(letter S) 7.97±2.53 12.33±3.72 0.001
WFT total 25.69±5.00 38.66±9.72 0.001
WCST (categories) 2.30±1.17 3.76±1.16 0.001
WCST (TM) 21.02±9.75 8.11±4.24 0.001
WCST (PE) 11.28±5.37 6.07±3.67 0.001
WCST (PR) 13.48±6.82 9.76±4.63 0.009
WCST (SL) 1.43±0.97 0.33±0.61 0.001
MFFT errors 9.64±3.71 6.78±4.08 0.002
MFFT time 372.28±89.34 343.92±105.57 0.165
JME, juvenile myoclonic epilepsy; ANCOVA, analysis of covariance; DF, Digit Span
Forward; DB, Digit Span Backward; SCWT, Stroop Color-Word Test; time, time to
completion; TMT, Trail Making Test; WFT, Word Fluency Test; WCST, Wisconsin
Card-Sorting Test; TM, total number of mistakes; PE, total number of incorrect
perseverative responses; PR, total number of correct perseverative responses; SL, set
loss; MFFT, Matching Familiar Figures Test.
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(p=0.001), and S (p=0.001), as well as in terms of the total score
(p=0.001); the WCST, in terms of the total number of correct
answers (p=0.002), total number of categories completed (p=
0.002), total number of mistakes (p=0.002), total number of incor-
rect perseverative responses (p=0.011), total number of correct
perseverative responses (p=0.004), and set loss (p=0.001); and
the Matching Familiar Figures Test, in terms of the number of errors
(p=0.001) and time to completion (p=0.001). There were no sig-
niﬁcant differences between the two groups in terms of the number
of mistakes on Stroop Color-Word Test 2 (p=0.384) and the number
of mistakes on Trail Making Test, part A (p=0.981).
3.2. Severity of attentional and executive dysfunction
In our evaluation of attentional and executive dysfunction in pa-
tients with JME, by comparing the outcome of tests of patients with
mean scores of the control subjects, we found that two patients
(4.76%) showed no dysfunction, ﬁve (11.9%) met the clinical criteria
for mild dysfunction, eight (19.04%) met the clinical criteria for
moderate dysfunction, and 27 (64.28%) met the clinical criteria for
severe dysfunction. Therefore, 95.23% of the patients presented
attentional/executive dysfunction, which was moderate or severe in
83.3% (35 of the 42 patients).
We also performed an individualized analysis, evaluating in which
tests patients with JME performed most poorly. The worst perfor-
mances were in the time to complete Stroop Color-Word Test 3 in
36 patients (85.71%); in the time to complete Stroop Color-Word
Test 1 in 35 (83.33%); in the time to complete Stroop Color-Word
Test 2 in 33 (78.57%); on the Digit Span Backward test in 27
(64.28%); on the Digit Span Forward test in 24 (57.14%); and on
the Trail Making Test, part B, in terms of the number of correct
responses in 21 patients (50.00%) and in the time to completion in
20 (47.61%).3.3. Correlation with clinical variables
Nineteen patients (45.23%) were seizure-free and 15 (35.71%)
had myoclonic seizures. Eight (19.04%) patients had sporadic GTC
seizures. Mean age of onset was 14 years (SD: 4.35). The epilepsy
duration considering epilepsy onset and treatment was 17.82 years.
All patients received sodium valprotate/divalproate. The mean dose
was 1.21 g (SD: ±0.67 g).
As to routine EEGs, performed in the same period of the neuropsy-
chological evaluation, no patients had electrographic or electroclinical
seizures; 35% had interictal epileptiform activity and 65% had a normal
EEG.
There was a signiﬁcant correlation between longer duration
of epilepsy and a longer time to complete Stroop Color-Word Test 1
(p=0.005), Stroop Color-Word Test 2 (p=0.007) and Stroop Color-
Word Test 3 (p=0.039). We also found that a higher frequency of
myoclonic seizures was correlated with a longer time to complete
Trail Making Test, part A (p=0.047). In addition, a higher frequency
of GTC seizures was correlated with a poorer performance on the
Digit Span Forward test (p=0.048), the Digit Span Backward test
(p=0.032), and Trail Making Test, part A (p=0.045), as well as
with a longer time to complete Trail Making Test, part B (p=0.048).
Higher doses of VPA were associated with a longer time to complete
Trail Making Test, part A (p=0.046) and part B (p=0.021); with
worse performance on the Word Fluency Test — total score (p=
0.047); the WCST, in terms of the total number of correct answers
(p=0.047), total number of categories completed (p=0.006), total
number of mistakes (p=0.001) and set loss (p=0.037).
History of psychiatric disorders was correlated with a longer time
to complete Trail Making Test, part A (p=0.001), as well as with
poorer performance on Word Fluency Test (p=0.046) (Table 2).
Presence of interictal EEG ﬁndings was not associated with worse
performance on any of the neuropsychological tests.
4. Discussion
The 42 patients with JME evaluated in the present study
performed more poorly on tests of executive and attentional func-
tions than did the control subjects, even when IQ was included as a
covariate.
Our results, obtained with an extensive battery of tests, not only
corroborate those of previous studies identifying executive dysfunc-
tion in patients with JME [10–14] but also describe which aspects
of executive functions, and especially of attentional functions, are
affected. In the present study, we demonstrated that patients with
JME perform poorly on tests of executive functions, showing speciﬁc
deﬁcits in working memory, inhibitory control, concept building,
goal maintenance, mental ﬂexibility, and verbal ﬂuency. We also
observed attentional deﬁcits ranging from the most basic, such as
alertness and attention span, to the most complex, such as those
requiring sustained and divided attention.
Although executive and attentional dysfunction was present
in most of the patients evaluated in the present study, there were
different levels of impairment. The severity of executive and atten-
tional dysfunction had not previously been measured in patients
with JME. Therefore, as previously mentioned, we employed the
clinical criteria proposed by Rzezak et al. [23] and determined that
83.3% of the patients presented either moderate or severe executive
and attentional dysfunction.
It should be borne in mind that there are quantitative differences
among patients with JME in terms of cognitive impairment. Although
most patients have executive dysfunction, it can manifest differently
and to varying degrees from patient to patient. Therefore, the impact
of such dysfunction varies.
We observed that distinct clinical variables had a signiﬁcant
impact on executive and attentional dysfunction. Longer duration of
Table 2
Pearson's correlation of clinical variables, and performance of patients with JME on neuropsychological tests.
Age of onset Duration of
epilepsy
Frequency of
myoclonic seizures
Frequency of
GTC seizures
Psychiatric
disorders
FH of epilepsy FH of psychiatric
disorders
DSF 0.238a 0.743a 0.452a 0.048a 0.514a 0.673a 0.332a
DSB 0.198a 0.916a 0.204a 0.032a 0.466a 0.762a 0.740a
SCWT-1 time 0.189a 0.005a 0.266a 0.117a 0.151a 0.951a 0.840a
SCWT-1 errors 0.285a 0.192a 0.327a 0.325a 0.331a 0.326a 0.324a
SCWT-2 time 0.080a 0.007a 0.208a 0.435a 0.089a 0.692a 0.988a
SCWT-2 errors 0.993a 0.944a 0.358a 0.368a 0.578a 0.619a 0.641a
SCWT-3 time 0.161a 0.039a 0.351a 0.918a 0.274a 0.938a 0.950a
SCWT-3 errors 0.301a 0.029a 0.148a 0.894a 0.766a 0.697a 0.308a
TMT-A time 0.531a 0.196a 0.047a 0.045a 0.001a 0.147a 0.435a
TMT-A errors 0.538a 0.762a 0.535a 0.790a 0.847a 0.154a 0.715a
TMT-B time 0.318a 0.270a 0.608a 0.048a 0.045a 0.946a 0.661a
TMT-B errors 0.535a 0.407a 0.051a 0.463a 0.181a 0.851a 0.439a
WFT total 0.732a 0.203a 0.076a 0.107a 0.046a 0.868a 0.109a
WCST(categories) 0.286a 0.265a 0.412a 0.670a 0.322a 0.919a 0.532a
WCST (TM) 0.535a 0.386a 0.097a 0.286a 0.058a 0.706a 0.493a
WCST (PE) 0.918a 0.944a 0.640a 0.734a 0.630a 0.721a 0.422a
WCST (PR) 0.811a 0.764a 0.463a 0.733a 0.591a 0.733a 0.312a
WCST (SL) 0.365a 0.343a 0.167a 0.586a 0.529a 0.782a 0483a
MFFT errors 0.264a 0.603a 0.163a 0.454a 0.202a 0.936a 0.957a
MFFT time 0.424a 0.082a 0.203a 0.393a 0.256a 0.975a 0.335a
DF, Digit Span Forward; DB, Digit Span Backward; FH, Family History; MFFT, Matching Familiar Figures Test; PE, total number of incorrect perseverative responses; PR, total number
of correct perseverative responses; SL, set loss; SCWT, Stroop Color-Word Test; time, time to completion; TM, total number of mistakes; TMT, Trail Making Test; WFT, Word Fluency
Test; WCST, Wisconsin Card-Sorting Test.
a Pearson's correlation (p).
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GTC seizures and the presence of psychiatric disorders were relevant
clinical variables. Our ﬁndings partially corroborate those of previous
studies in which the duration of epilepsy was identiﬁed as an impor-
tant factor for cognitive function in JME [6]. However, unlike other
authors, we did not ﬁnd the cognitive performance of patients
with JME to correlate with a family history of epilepsy [13], an earlier
age of onset, or absence seizures [13,14]. We also found that attentional
processes, such as attention span, sustained attention, and divided atten-
tion, more often correlated with clinical variables than did executive
function. Mental ﬂexibility, concept formation, and planning were unaf-
fected by clinical variables.
The association between AED dose and poorer performance must
be seen with caution. Some AEDs are known for their impact on
cognitive function, such as topiramate [24] and phenobarbital [25].
However, the relevance of VPA for cognitive functions is controversial
[26]. It is important to remember that patients using higher doses of
VPA were those with higher seizure frequency. Therefore, there is
an overlap between the drug itself and more severe epilepsy. In this
series, patients in need of higher doses of VPA had worse performance
on and required a longer time to complete the Trail Making Test, part
A and part B, with worse performance on the Word Fluency Test; and
with worse performance on theWCST, in terms of the total number of
correct answers and total number of categories completed.
Subclinical epileptiform discharges may affect the neuropsycho-
logical performance as demonstrated by Sieblink et al. [27]. In our
study, there was no correlation between EEG ﬁndings and neuropsy-
chological tests. Although, our neuropsychological evaluation was
done without concomitant video-EEG, we must take into account
that for this study, the patients had gone at least 48 h without
seizures, including myoclonic seizures. In addition, all the patients
were under treatment with AEDs, in this case VPA, and most had
normal EEGs without interictal epileptiform activity at the moment
of the evaluation. None of them had ictal epileptiform discharges.
Although the comprehensive battery indicated executive and
attentional impairment, some domains were more affected than
others, when the number of patients with worse performance in
each group was analyzed. Most patients in this study exhibited
worst performance on the WCST (mental ﬂexibility), TMT (sustained
and alternate attention), Stroop Color-Word Test (inhibitory control)and Digit Span (workingmemory). Most testing sessions are currently
time limited, and a determination of the relative efﬁcacy of the tests
may be helpful in establishing a set of tests for clinical practice.
In the majority of the patients with JME, we observed that the
paradigms used to evaluate attentional functioning, from the simple
(attention span) to the complex (sustained and divided attention),
are those in which the patients with JME perform most poorly.
Attentional processes play a pivotal role in executive functioning
and must be considered as an integral part of this functional system.
Our ﬁndings indicate the need for comprehensive neuropsychological
batteries in order to provide a more extensive evaluation of attentional
and executive functions in patients with JME, as well as showing that
certain relevant deﬁcits have been neglected.
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